Though TB remains the world's top infectious disease killer, there's cause for hope, Fred Hutch Cancer Center experts say.

Barbara Doyle had just moved to Washington when she began to experience unusual nosebleeds. Her son-in-law recommended UW ...

Join us as we explore the latest advancements in immunotherapy at Fred Hutch, including CAR T-cell therapy, novel agents, ...

Fred Hutch Cancer Center’s Rare Cancer Patient and Caregivers’ Symposium held March 14 and sponsored by TRACER, Fred Hutch's ...

SEATTLE — Feb. 26, 2026 — Fred Hutch Cancer Center announced 12 recipients of the Harold M. Weintraub Graduate Student Award, which honors the exceptional achievements of graduate students in the ...

We asked Fred Hutch experts for their best advice on how people in Washington state can still get cancer screenings even ...

In this episode of From Bench to Bedside and Beyond, Dr. Yaw Nyame and patient Dave Lucas discuss the robotic surgical ...

Philanthropy fuels Fred Hutch’s breakthroughs. Our community's support drives world-changing discoveries, strengthens patient and caregiver experiences, and helps build the next generation of ...

The Biostatistics, Bioinformatics and Epidemiology Program (BBE) supplies the statistical and mathematical modeling expertise needed within Fred Hutch’s Vaccine and Infectious Disease Division to ...

SEATTLE – February 17, 2026 – Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein-Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is ...

Over the last decade, the cellular cancer immunotherapy known as CAR T-cell therapy has roared to the rescue of many blood cancer patients. The engineered immune cells revolutionized treatment of ...

Researchers from two labs in the Human Biology division at Fred Hutch Cancer Center recently published two studies aimed at ...